Allogene Therapeutics
Madhu Nagaram is a seasoned IT professional with extensive experience in information technology management and database administration. Currently serving as a Senior Information Technology Manager at Allogene Therapeutics since September 2020, Madhu previously held key positions, including Program Manager at Smiths Detection and IT Operations Manager at VMware. An accomplished expert in Oracle applications, Madhu has worked in various roles across multiple organizations, including EDS, CellMark, Bimbo Bakeries USA, and Cisco. Educational qualifications include an MBA in International Business from California State University-Dominguez Hills, a Master's in Computer Science from Lamar University, and a Bachelor's in Mechanical Engineering from Sri Venkateswara University.
Allogene Therapeutics
1 followers
Allogene Therapeutics is a clinical-stage biotechnology company pioneering the development of allogeneic chimeric antigen receptor T cell (AlloCAR T™) therapies for cancer. The goal of our allogeneic cell therapy platform is simple: take the same biological processes that allow the first generation autologous CAR T therapies to deliver breakthrough clinical benefits but eliminate the need to create a personalized therapy for each patient. Instead, we start with T cells from healthy donors, which is intended to allow for creation of inventory for “off-the-shelf” use in patients faster, more reliably, and at greater scale.